The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease

被引：0
|
作者：
Macaluso, F. S. [1 ]
Grova, M. [1 ]
Saladino, M. [2 ]
Demarzo, M. G. [3 ]
Privitera, A. C. [4 ]
Giangreco, E. [5 ]
Garufi, S. [6 ]
Renna, S. [1 ]
Casa, A. [1 ]
Ventimiglia, M. [7 ]
Cappello, M. [2 ]
Fries, W.
Orlando, A. [1 ]
机构：
[1] Osped Riuniti Villa Sofia Cervello, IBD Unit, Palermo, Italy
[2] Univ Palermo, Gastroenterol & Hepatol Sect Promise, Palermo, Italy
[3] Univ Messina, IBD Unit, Messina, Italy
[4] Cannizzaro Hosp, IBD Unit, Catania, Italy
[5] Guzzardi Hosp, Gastroenterol Unit, Vittoria, Italy
[6] ARNAS Garibaldi, Gastroenterol Unit, Catania, Italy
[7] Italian Minist Hlth, Directorate Gen Med Device & Pharmaceut Serv, Rome, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P345
引用
收藏
页码：I359 / I359
页数：1
相关论文
共 50 条
  • [41] Ustekinumab versus Vedolizumab for Moderate to Severe Crohn's Disease
    Singh, Amandeep
    Khan, Freeha
    Lopez, Rocio
    Shen, Bo
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S393 - S394
  • [42] EFFICACY AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB FOR CROHN'S DISEASE OF THE POUCH
    Park, Sunhee
    Keyashian, Kian
    Ho, Andrew
    Limsui, David
    Frost, Spencer
    Vazquez-Reyes, Raul
    Ebriani, Joseph
    Yang, Eleanor
    Parekh, Nimisha K.
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S146 - S146
  • [43] REAL WORLD EFFECTIVENESS OF USTEKINUMAB FOR REFRACTORY CROHN'S DISEASE: A REGIONAL EXPERIENCE
    Mcgregor, Colleen
    Tarafdar, Adib
    Hussain, Moheez
    Griffiths, Cameron
    Chapman, Thomas
    Adams, Alex
    Wong, Darren
    Cripps, Sarah
    Brain, Oliver
    Ambrose, Timothy
    Palmer, Rebecca
    De Silva, Aminda
    Walsh, Alissa
    Travis, Simon
    Satsangi, Jack
    [J]. GUT, 2021, 70 : A108 - A108
  • [44] COST-EFFECTIVENESS OF VEDOLIZUMAB VERSUS USTEKINUMAB IN UNITED KINGDOM CROHN'S DISEASE PATIENTS WHO PREVIOUSLY FAILED TNF INHIBITOR THERAPY
    Wilson, M.
    Lucas, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S145 - S145
  • [45] Safety and effectiveness of ustekinumab in elderly Crohn's disease patients
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy K.
    Conley, Thomas E.
    Townsend, Tristan
    Davies, Mike
    Brockwell, Robert
    Baig, Daniyal
    Abdelbadiee, Sherif
    Uney, Anastasia
    Liaros, Angela
    Gaba, Waqas
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (11) : 1132 - 1139
  • [46] Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease
    Ollech, Jacob E.
    Normatov, Inessa
    Peleg, Noam
    Wang, Jingzhou
    Patel, Shivani A.
    Rai, Victoria
    Yi, Yangtian
    Singer, Jorie
    Dalal, Sushila R.
    Sakuraba, Atsushi
    Cohen, Russell D.
    Rubin, David T.
    Pekow, Joel
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (01) : 104 - 110
  • [47] COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY
    Townsend, Tristan
    Razanskaite, Violeta
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Storey, Daniel
    Watters, Christopher
    Penman, Douglas
    Swaminathan, Mira
    Reilly, Ian
    Flanagan, Paul
    Subramanian, Sreedhar
    [J]. GUT, 2021, 70 : A127 - A127
  • [48] Comparison of Surgical Rates in Biologic Naive Crohn's Disease Patients on Ustekinumab and Vedolizumab
    Mohammed, Abdul
    Alchirazi, Khaled Alsabbagh
    Hamid, Osama
    Eltelbany, Ahmed
    Garg, Rajat
    Paranji, Neethi
    Gonzaga, Ernesto Robalino
    Singh, Amandeep
    Kais, Susan
    Regueiro, Miguel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S706 - S707
  • [49] Long term efficacy of ustekinumab in Crohn's disease patients after vedolizumab failure
    Melotti, L.
    Dussias, N. K.
    Belluzzi, A.
    Salice, M.
    Calabrese, C.
    Rizzello, F.
    Gionchetti, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I408 - I408
  • [50] Long term efficacy of ustekinumab in Crohn's disease patients after vedolizumab failure
    Melotti, L.
    Dussias, N. K.
    Belluzzi, A.
    Salice, M.
    Calabrese, C.
    Rizzello, F.
    Gionchetti, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I408 - I408
12345